Seattle Genetics Inc. (SGEN) Tops Q1 EPS by 7c
Tweet Send to a FriendGet Alerts SGEN Hot Sheet
Price: $36.70 +1.05%
EPS Growth %: -27.3%
Financial Fact:
Revenue from collaboration and license agreements: 21.01M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: -27.3%
Financial Fact:
Revenue from collaboration and license agreements: 21.01M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade SGEN Now!
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q1 EPS of ($0.30), $0.07 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $9.84 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
- ReneSola Ltd. (SOL) Posts Q1 Loss of 45c/ADS; Guides Q2, FY13 Shipments
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
